Syncona's Autolus Therapeutics Reports Progress On Therapy Development
LONDON (Alliance News) - FTSE 250-listed healthcare-focused investor Syncona Ltd on Monday reported on progress made by portfolio company, Nasdaq-listed Autolus Therapeutics Inc, on its has dosed Read More